Arbutus Biopharma Corporation (ABUS)

Arbutus Biopharma Market Cap

Arbutus Biopharma has a market cap or net worth of $830.96 million as of October 26, 2026. It is the 11,145th most valuable company in the world and the 2,355th biggest in the United States. Its market cap has decreased by 0.58% in one year.

• Market Cap: 830.96M
• Enterprise Value: 741.96M
• 1-Year Change: -0.58%
• Global Rank: #11,145
• Country Rank: #2,355 United States
• Category: Small-Cap

Market Cap Chart

Chart

Since December 31, 2009, Arbutus Biopharma's market cap has increased from $47.50M to $830.96M, an increase of 1,649.39%. That is a compound annual growth rate of 18.54%.

Market Cap History

Date	Market Cap	% Change
Oct 26, 2026	830.96M	-10.18%
Dec 31, 2025	925.10M	49.31%
Dec 31, 2024	619.60M	47.81%
Dec 29, 2023	419.20M	14.98%
Dec 30, 2022	364.60M	-30.71%
Dec 31, 2021	526.20M	74.59%
Dec 31, 2020	301.40M	90.76%
Dec 31, 2019	158.00M	-25.65%
Dec 31, 2018	212.50M	-23.56%
Dec 29, 2017	278.00M	106.85%
Dec 30, 2016	134.40M	-44.65%
Dec 31, 2015	242.80M	-28.19%
Dec 31, 2014	338.10M	196.58%
Dec 31, 2013	114.00M	89.05%
Dec 31, 2012	60.30M	289.03%
Dec 30, 2011	15.50M	-68.04%
Dec 31, 2010	48.50M	2.11%
Dec 31, 2009	47.50M	-
Dec 31, 2009	47.50M	-

View and export this data all the way back to 2009. Sign Up Today.

Data Source: Nasdaq Data Link Last updated: Oct 23, 2026

Market cap data is provided by Nasdaq Data Link. The current market cap updates continuously throughout the trading day, while the historical market cap is updated daily after market close.

Update frequency:

Daily

Last checked:

Oct 26, 2026

Data Sources Report a data error

Related Stocks

Company	Market Cap
Rigel Pharmaceuticals	899.06M
Corvus Pharmaceuticals	885.79M
MeiraGTx Holdings	884.56M
Alumis	877.57M
Aktis Oncology	874.89M
Obsidian Therapeutics	863.58M
Alto Neuroscience	862.15M
Kura Oncology	854.91M